Growth opportunities remain in cannabis, but it requires creativity, enterprise and knowledge, according to top investors. Take this for an investing conundrum: Where do you put your money in an industry with enormous upside but where many companies don’t yet make profits? An industry where some states consider it “essential business” but the country considers its product illegal? Or an…
As more and more states begin to legalize marijuana while its medicinal benefits are being more widely used, the cannabis industry has become a hotbed of investment opportunities. Here are four things that you need to know if you are considering investing in the cannabis industry. Understanding the Cannabis Market: Although the possession of marijuana is not legal on a…
Marijuana is a high-growth industry. However, there are a few things you should know before investing in the green rush. READ MORE: https://finance.yahoo.com/m/fa1bc567-886d-3ef6-87f1-fdcfabfee154/the-3-must-knows-of-cannabis.html?.tsrc=rss
You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight to help our readers stay ahead of the curve as well as links to the week’s most important news. Subscribe to receive our free weekly newsletter in […] READ MORE: https://www.newcannabisventures.com/smarter-strategic-investments-are-likely-ahead-in-the-third-wave-of-cannabis-investing/
Following up on the theme we discussed in this weekend’s newsletter regarding our view that a “third wave” in cannabis investing has commenced, we published an extensive review of the past seven years and our outlook for what lies ahead at Seeking Alpha. If you aren’t familiar with Seeking Alpha, it is a crowd-sourced publishing […] READ MORE: https://www.newcannabisventures.com/diving-deep-into-the-third-wave-of-cannabis-investing/
Exclusive Interview with Columbia Care Co-Founder, CEO and Director Nicholas Vita Columbia Care (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) is licensed in 18 U.S. states and has operations in Europe. In 2020, the company is gearing up to become profitable across its footprint. Co-Founder, CEO and Director Nicholas Vita spoke with New Cannabis Ventures about […] READ MORE: https://www.newcannabisventures.com/columbia-care-is-prepared-to-profit-after-investing-in-cannabis-operations/
The economic fallout from the coronavirus crisis will be massive. With the U.S. already sliding into a recession, experts say it may take years for Americans to recover financially. With the economy in such a state, would it be wise to invest? Wouldn’t it be better to hold onto those funds and see how things play out? Well, it depends…
Psychedelics are rapidly becoming both a mainstream treatment option and investment opportunity. With growing interest among researchers, forward-thinking companies are starting to build a presence in the space. In this article, we will take a look at the growing body of therapeutic evidence for psychedelics. How decriminalization is gaining ground, and how Ehave Inc. (OTC: EHVVF) along with other public…
Remember when investments in cannabis and Bitcoin were seen as interchangeable pursuits of the next sky-high return based on a story that sounded plausible, if not downright enticing? In the early days, cannabis investors chased Canadian operators focused on ramping up production to meet the growing demand of a newly legalized Canadian recreation market and, ultimately, booming markets in the…
Canopy Growth Corp (NYSE: CGC) (TSE: WEED) announced the appointment Tuesday of Judy Hong as vice president of investor relations. Hong will lead the company’s IR department along with Tyler Burns with the goal of developing and strengthening the program, according to the cannabis company. Hong has over 20 years of experience at Goldman Sachs Group Inc (NYSE: GS), where she…
The expectation has long been that marijuana would be among the fastest-growing industries in the world over the next decade. We’ve already witnessed global cannabis sales more than triple over the past four years, and know that tens of billions of dollars in sales are undertaken annually in the black market. The demand is there — it’s simply a matter…
Revenue $43.4 million, adjusted EBITDA $10.1 million BARRIE, Ontario, Nov. 12, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation and purification, today announced its financial results for the three and nine months ended September 30, 2019. During the period the Company…